Name | tert-butyl 4-[4-(hydroxymethyl)phenyl]piperazine-1-carboxylate |
---|---|
Synonyms |
TERT-BUTYL 4-[4-(HYDROXYMETHYL)PHENYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE
1-hydroxymethyl-4-(4-(1,1-dimethylethoxycarbonyl)piperazinyl)benzene 1-(tert-Butoxycarbonyl)-4-(4-hydroxymethylphenyl)piperazine 4-(4-N-Boc-piperazinyl)benzyl alcohol tert-Butyl 4-(4-(hydroxymethyl)phenyl)piperazine-1-carboxylate |
Density | 1.152g/cm3 |
---|---|
Boiling Point | 452ºC at 760mmHg |
Melting Point | 109ºC |
Molecular Formula | C16H24N2O3 |
Molecular Weight | 292.37300 |
Flash Point | 227.2ºC |
Exact Mass | 292.17900 |
PSA | 53.01000 |
LogP | 2.23890 |
Vapour Pressure | 5.86E-09mmHg at 25°C |
Index of Refraction | 1.553 |
Hazard Codes | Xi: Irritant; |
---|---|
HS Code | 2933599090 |
~88% 158985-37-6 |
Literature: VERTEX PHARMACEUTICALS INCORPORATED Patent: WO2007/27528 A2, 2007 ; Location in patent: Page/Page column 47-48 ; WO 2007/027528 A2 |
~75% 158985-37-6 |
Literature: Merck Sharpe and Dohme Ltd. Patent: US5432177 A1, 1995 ; |
Precursor 2 | |
---|---|
DownStream 0 |
HS Code | 2933599090 |
---|---|
Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |